Cargando…

Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare

INTRODUCTION: Generalized pustular psoriasis (GPP) is a rare, potentially life-threatening disease characterised by recurrent flares of widespread neutrophilic aseptic skin pustular eruption. Despite the availability of approved biologics for GPP in Japan, Taiwan and Thailand, associated evidence is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choon, Siew Eng, Lebwohl, Mark G, Marrakchi, Slaheddine, Burden, A David, Tsai, Tsen-Fang, Morita, Akimichi, Navarini, Alexander A, Zheng, Min, Xu, Jinhua, Turki, Hamida, Rajeswari, Sushmita, Deng, Hongjie, Tetzlaff, Kay, Thoma, Christian, Bachelez, Hervé
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Dermatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011793/ https://www.ncbi.nlm.nih.gov/pubmed/33785490 http://dx.doi.org/10.1136/bmjopen-2020-043666

Ejemplares similares

Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis
por: Morita, Akimichi, et al.
Publicado: (2022)

Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double‐blind, placebo‐controlled Effisayil™ 1 study
por: Morita, Akimichi, et al.
Publicado: (2022)

Efficacy and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Subgroup Analysis of Chinese Patients in the Effisayil 1 Trial
por: Tsai, Tsen-Fang, et al.
Publicado: (2023)

Clinical Characteristics and Outcomes of Generalized Pustular Psoriasis Flares
por: Choon, Siew Eng, et al.
Publicado: (2023)

Rapid response of spesolimab in biologics – failure patient with generalized pustular psoriasis flare
por: Jiang, Meng, et al.
Publicado: (2023)

Pathophysiology of Generalized Pustular Psoriasis
por: Marrakchi, Slaheddine, et al.
Publicado: (2022)

Spesolimab use in treatment of pyoderma gangrenosum
por: Guénin, Sophie H., et al.
Publicado: (2023)

Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study
por: Burden, A. David, et al.
Publicado: (2023)

Clinical Disease Measures in Generalized Pustular Psoriasis
por: Burden, A. David, et al.
Publicado: (2022)

Spesolimab: First Approval
por: Blair, Hannah A.
Publicado: (2022)

Commentary on a Clinical Trial of Spesolimab, a Humanized Anti-interleukin-36 Receptor Monoclonal Antibody, in Generalized Pustular Psoriasis
por: Shao, Shuai, et al.
Publicado: (2022)

Correction to: Spesolimab: First Approval
por: Blair, Hannah A.
Publicado: (2022)

Clinical Course and Characteristics of Generalized Pustular Psoriasis
por: Choon, Siew Eng, et al.
Publicado: (2022)

Pustular Psoriasis: The Dawn of a New Era
por: BACHELEZ, Hervé
Publicado: (2020)

A pustular psoriasis flare treated with calcium supplementation
por: Masson, Laure, et al.
Publicado: (2021)

Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study
por: Mrowietz, Ulrich, et al.
Publicado: (2021)

Great imitator with exclusive oral manifestations
por: Hayder, Faten, et al.
Publicado: (2022)

Unmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry Dermatologists
por: Strober, Bruce, et al.
Publicado: (2021)

Congenital lamellar ichthyosis in Tunisia is caused by a founder nonsense mutation in the TGM1 gene
por: Louhichi, Nacim, et al.
Publicado: (2012)

Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records
por: Zema, Carla L., et al.
Publicado: (2022)

Tozinameran: Flare-up of generalised pustular psoriasis and systemic capillary leak syndrome: case report
Publicado: (2022)

Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study
por: Bellinato, Francesco, et al.
Publicado: (2023)

A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: Case report
por: Onsun, Nahide, et al.
Publicado: (2021)

Response to “New-onset pustular psoriasis in the setting of severe acute respiratory syndrome coronavirus 2 infection causing coronavirus disease 2019”
por: Assan, Florence, et al.
Publicado: (2021)

Clinical and genetic differences between pustular psoriasis subtypes
por: Twelves, Sophie, et al.
Publicado: (2019)

Identification of a novel missense mutation in NIPAL4 gene: First 3D model construction predicted its pathogenicity
por: Laadhar, Sahar, et al.
Publicado: (2019)

Clinical and genetic investigation of ichthyosis in familial and sporadic cases in south of Tunisia: genotype–phenotype correlation
por: Ennouri, Mariem, et al.
Publicado: (2022)

Quantification of Efflorescences in Pustular Psoriasis Using Deep Learning
por: Amruthalingam, Ludovic, et al.
Publicado: (2022)

Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP)
por: Burden, A. David, et al.
Publicado: (2022)

Loss-of-Function Myeloperoxidase Mutations Are Associated with Increased Neutrophil Counts and Pustular Skin Disease
por: Vergnano, Marta, et al.
Publicado: (2020)

Loss-of-function myeloperoxidase mutations are associated with increased neutrophil counts and pustular skin disease
por: Vergnano, Marta, et al.
Publicado: (2021)

Assessment of the Pharmacokinetics and Safety of Spesolimab, a Humanised Anti-interleukin-36 Receptor Monoclonal Antibody, in Healthy Non-Japanese and Japanese Subjects: Results from Phase I Clinical Studies
por: Joseph, David, et al.
Publicado: (2022)

Remission einer therapierefraktären generalisierten pustulösen Psoriasis unter dem Interleukin-36-Rezeptor-Inhibitor Spesolimab
por: Müller, Valentina Laura, et al.
Publicado: (2023)

Thyroid involvement in Chanarin-Dorfman syndrome in adults in the largest series of patients carrying the same founder mutation in ABHD5 gene
por: Louhichi, Nacim, et al.
Publicado: (2019)

Patient characteristics and burden of disease in Japanese patients with generalized pustular psoriasis: Results from the Medical Data Vision claims database
por: Morita, Akimichi, et al.
Publicado: (2021)

Ixekizumab 80 mg Every 2 Weeks Treatment Beyond Week 12 for Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis
por: Morita, Akimichi, et al.
Publicado: (2021)

Mutations in CERS3 Cause Autosomal Recessive Congenital Ichthyosis in Humans
por: Radner, Franz P. W., et al.
Publicado: (2013)

Correction: Mutations in CERS3 Cause Autosomal Recessive Congenital Ichthyosis in Humans
por: Radner, Franz P. W., et al.
Publicado: (2013)

Chronic annular pustular psoriasis resembling subcorneal pustular dermatosis: A case report
por: Khosravi-Hafshejani, Touraj, et al.
Publicado: (2019)

Myeloperoxidase Modulates Inflammation in Generalized Pustular Psoriasis and Additional Rare Pustular Skin Diseases
por: Haskamp, Stefan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b4380i3u6cpri5jq0vl3fhqafl